From: Glutamine, fish oil and antioxidants in critical illness: MetaPlus trial post hoc safety analysis
Parameter | Parameter estimate | Standard error | Hazard ratio | 95% CI of the hazard ratio | P value |
---|---|---|---|---|---|
1a: Medical patients (n = 109) | |||||
IMHP versus HP | 0.922 | 0.319 | 2.515 | [1.360, 4.783] | 0.004 |
Age group 1 versus 4 | −2.651 | 0.788 | 0.071 | [0.011, 0.275] | <0.001 |
Age group 2 versus 4 | −1.439 | 0.393 | 0.237 | [0.110, 0.522] | <0.001 |
Age group 3 versus 4 | −1.120 | 0.409 | 0.326 | [0.145, 0.733] | 0.006 |
APACHE-II score | 0.017 | 0.019 | 1.017 | [0.980, 1.057] | 0.376 |
2a: Non-medical patients (n = 192) | |||||
IMHP versus HP | −0.034 | 0.296 | 0.967 | [0.540, 1.736] | 0.909 |
Age group 1 versus 4 | −1.595 | 0.533 | 0.203 | [0.068, 0.562] | 0.003 |
Age group 2 versus 4 | −1.489 | 0.434 | 0.226 | [0.095, 0.531] | <0.001 |
Age group 3 versus 4 | −0.467 | 0.381 | 0.627 | [0.299, 1.353] | 0.219 |
APACHE-II score | 0.101 | 0.026 | 1.106 | [1.052, 1.165] | <0.001 |